116 related articles for article (PubMed ID: 36650958)
1. Criterion validity of the spatial exploration test of upper limb mobility to evaluate the active horizontal workspace of children with spinal muscular atrophy.
Pruvost S; Gomez Garcia de la Banda M; Quijano Roy S; Izedaren F; Roche N; Pouplin S
Disabil Rehabil; 2024 Feb; 46(3):575-580. PubMed ID: 36650958
[TBL] [Abstract][Full Text] [Related]
2. Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen.
Le Goff L; Seferian A; Phelep A; Rippert P; Mathieu ML; Cances C; de Lattre C; Durigneux J; Gousse G; Vincent-Genod D; Ribault S; Gomez Garcia de la Banda M; Quijano-Roy S; Sarret C; Servais L; Vuillerot C
Neurol Sci; 2023 Jan; 44(1):329-337. PubMed ID: 36175810
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
[TBL] [Abstract][Full Text] [Related]
4. The applicability of four clinical methods to evaluate arm and hand function in all stages of spinal muscular atrophy type II.
Werlauff U; Fynbo Steffensen B
Disabil Rehabil; 2014; 36(25):2120-6. PubMed ID: 24579651
[TBL] [Abstract][Full Text] [Related]
5. Digital measures of respiratory and upper limb function in spinal muscular atrophy: design, feasibility, reliability, and preliminary validity of a smartphone sensor-based assessment suite.
Perumal TM; Wolf D; Berchtold D; Pointeau G; Zhang YP; Cheng WY; Lipsmeier F; Sprengel J; Czech C; Chiriboga CA; Lindemann M;
Neuromuscul Disord; 2023 Nov; 33(11):845-855. PubMed ID: 37722988
[TBL] [Abstract][Full Text] [Related]
6. [Validity of the motor function measurement scale when routinely used in the follow-up of adult outpatients in a neuromuscular center].
Benaïm C; Sacconi S; Fournier-Mehouas M; Tanant V; Desnuelle C
Rev Neurol (Paris); 2010 Jan; 166(1):49-53. PubMed ID: 19524275
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the upper limb function, strength, and mobility in treatment-naive children with spinal muscular atrophy Types 2 and 3.
Milev E; Selby V; Wolfe A; Rohwer A; Tillmann R; Ramsey D; Iodice M; Hogrel JY; Baranello G; Scoto M; Muntoni F
Muscle Nerve; 2024 Mar; 69(3):340-348. PubMed ID: 38238963
[TBL] [Abstract][Full Text] [Related]
8. Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study.
Audic F; de la Banda MGG; Bernoux D; Ramirez-Garcia P; Durigneux J; Barnerias C; Isapof A; Cuisset JM; Cances C; Richelme C; Vuillerot C; Laugel V; Ropars J; Altuzarra C; Espil-Taris C; Walther-Louvier U; Sabouraud P; Chouchane M; Vanhulle C; Trommsdorff V; Pervillé A; Testard H; Lagrue E; Sarret C; Avice AL; Beze-Beyrie P; Pauly V; Quijano-Roy S; Chabrol B; Desguerre I
Orphanet J Rare Dis; 2020 Jun; 15(1):148. PubMed ID: 32532349
[TBL] [Abstract][Full Text] [Related]
9. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy.
Alfano LN; Miller NF; Iammarino MA; Moore Clingenpeel M; Lowes SL; Dugan ME; Kissel JT; Al Zaidy S; Tsao CY; Lowes LP
Dev Med Child Neurol; 2020 Mar; 62(3):303-309. PubMed ID: 30963554
[TBL] [Abstract][Full Text] [Related]
10. Revised upper limb module for spinal muscular atrophy: Development of a new module.
Mazzone ES; Mayhew A; Montes J; Ramsey D; Fanelli L; Young SD; Salazar R; De Sanctis R; Pasternak A; Glanzman A; Coratti G; Civitello M; Forcina N; Gee R; Duong T; Pane M; Scoto M; Pera MC; Messina S; Tennekoon G; Day JW; Darras BT; De Vivo DC; Finkel R; Muntoni F; Mercuri E
Muscle Nerve; 2017 Jun; 55(6):869-874. PubMed ID: 27701745
[TBL] [Abstract][Full Text] [Related]
11. Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.
Montes J; Glanzman AM; Mazzone ES; Martens WB; Dunaway S; Pasternak A; Riley SO; Quigley J; Pandya S; De Vivo DC; Kaufmann P; Chiriboga CA; Finkel RS; Tennekoon GI; Darras BT; Pane M; Mercuri E; Mcdermott MP;
Muscle Nerve; 2015 Dec; 52(6):942-7. PubMed ID: 25846132
[TBL] [Abstract][Full Text] [Related]
12. English cross-cultural translation and validation of the neuromuscular score: a system for motor function classification in patients with neuromuscular diseases.
Vuillerot C; Meilleur KG; Jain M; Waite M; Wu T; Linton M; Datsgir J; Donkervoort S; Leach ME; Rutkowski A; Rippert P; Payan C; Iwaz J; Hamroun D; Bérard C; Poirot I; Bönnemann CG
Arch Phys Med Rehabil; 2014 Nov; 95(11):2064-2070.e1. PubMed ID: 24862765
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in respiratory and upper limb function in a pediatric type III spinal muscular atrophy cohort after loss of ambulation.
Wolfe A; Scoto M; Milev E; Muni Lofra R; Abbott L; Wake R; Rohwer A; Main M; Baranello G; Mayhew A; Marini-Bettolo C; Muntoni F
Muscle Nerve; 2021 Nov; 64(5):545-551. PubMed ID: 34432301
[TBL] [Abstract][Full Text] [Related]
14. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.
Pechmann A; Behrens M; Dörnbrack K; Tassoni A; Wenzel F; Stein S; Vogt S; Zöller D; Bernert G; Hagenacker T; Schara-Schmidt U; Walter MC; Bertsche A; Vill K; Baumann M; Baumgartner M; Cordts I; Eisenkölbl A; Flotats-Bastardas M; Friese J; Günther R; Hahn A; Horber V; Husain RA; Illsinger S; Jahnel J; Johannsen J; Köhler C; Kölbel H; Müller M; von Moers A; Schwerin-Nagel A; Reihle C; Schlachter K; Schreiber G; Schwartz O; Smitka M; Steiner E; Trollmann R; Weiler M; Weiß C; Wiegand G; Wilichowski E; Ziegler A; Lochmüller H; Kirschner J;
Orphanet J Rare Dis; 2022 Oct; 17(1):384. PubMed ID: 36274155
[TBL] [Abstract][Full Text] [Related]
15. Correlations between clinical motor scores and CMAP in patients with type 2 spinal muscular amyotrophy treated with nusinersen.
Richard M; Barrois R; Desguerre I; Deladrière E; Leloup-Germa V; Barnerias C; Gitiaux C
Arch Pediatr; 2024 Jan; 31(1):26-31. PubMed ID: 37989659
[TBL] [Abstract][Full Text] [Related]
16. Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy.
Vázquez-Costa JF; Povedano M; Nascimiento-Osorio AE; Moreno Escribano A; Kapetanovic Garcia S; Dominguez R; Exposito JM; González L; Marco C; Medina Castillo J; Muelas N; Natera de Benito D; Ñungo Garzón NC; Pitarch Castellano I; Sevilla T; Hervás D
Eur J Neurol; 2022 Dec; 29(12):3666-3675. PubMed ID: 36047967
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in Collagen VI-Related Dystrophies and Laminin Alpha2-Related Muscular Dystrophy.
Le Goff L; Meilleur KG; Norato G; Rippert P; Jain M; Fink M; Foley AR; Waite M; Donkervoort S; Bönnemann CG; Vuillerot C
Arch Phys Med Rehabil; 2021 Apr; 102(4):604-610. PubMed ID: 33166523
[TBL] [Abstract][Full Text] [Related]
18. Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study.
Annoussamy M; Seferian AM; Daron A; Péréon Y; Cances C; Vuillerot C; De Waele L; Laugel V; Schara U; Gidaro T; Lilien C; Hogrel JY; Carlier P; Fournier E; Lowes L; Gorni K; Ly-Le Moal M; Hellbach N; Seabrook T; Czech C; Hermosilla R; Servais L;
Ann Clin Transl Neurol; 2021 Feb; 8(2):359-373. PubMed ID: 33369268
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment for spinal muscular atrophy types II and III.
Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD006282. PubMed ID: 32006461
[TBL] [Abstract][Full Text] [Related]
20. [Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy].
Escobar RG; Lucero N; Solares C; Espinoza V; Moscoso O; Olguín P; Muñoz KT; Rosas R
Rev Chil Pediatr; 2017 Feb; 88(1):92-99. PubMed ID: 28288228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
